congenital amegakaryocytic thrombocytopenia camt rare autosomal recessive bone marrow failure syndrome characterized severe thrombocytopenia progress aplastic anemia camt usually manifests thrombocytopenia initial month life fetal phase typically campt presents petechiae cerebral bleeds recurrent rectal bleeding pulmonary cause camt believed mutations mpl gene coding thrombopoietin receptor expressed pluripotent hematopoietic stem cells cells megakaryocyte camt diagnosed bone marrow biopsy often initially suspected fetal neonatal alloimmune two types congenital amegakaryocytic thrombocytopenia identified type treatment mostly supportive consisting multiple platelet transfusions hematopoietic stem cell transplantation known cure pancytopenia develops prognosis poor studies shown camt patients die bleeding complications another die complications related hematopoietic stem cell congenital amegakaryocytic thrombocytopenia manifests birth typically within first days birth thrombocytopenia near absence megakaryocytes bone marrow cause petechiae purpura gastrointestinal pulmonary intracranial less common symptoms campt include cardiac defects atrial ventricular septal defects cerebral cerebellar hypoplasia delayed psychomotor type congenital amegakaryocytic thrombocytopenia often progress bone marrow failure aplastic anemia around age type ii usually dont develop bone marrow failure aplastic anemia till age type ii camt develop rates pancytopenia much lower type increased risk myelodysplastic syndrome acute myeloid leukemia associated congenital amegakaryocytic congenital amegakaryocytic thrombocytopenia likely caused mutation gene tpo receptor cmpl despite high levels serum addition may abnormalities central nervous system including cerebrum cerebellum could cause main diagnostic features congenital amegakaryocytic thrombocytopenia elevated serum tpo levels respond tpo stimulation absent megakaryocytes bone marrow thrombocytopenia worsens congenital amegakaryocytic thrombocytopenia confirmed homozygous compound heterozygous mutations cmpl differential diagnosis congenital amegakaryocytic thrombocytopenia includes thrombocytopeniaabsent radius syndrome wiskottaldrich syndrome congenital amegakaryocytic thrombocytopenia distinguished thrombocytopeniaabsent radius syndrome basis skeletal hypoplasia arms absence microthrombocytopenia rule wiskottaldrich two types congenital amegakaryocytic thrombocytopenia identified type icamt severe characterized low platelet counts early progression bone marrow aplasia associated second type congenital amegakaryocytic thrombocytopenia milder presents transient increase platelet counts first year life type iicamt often dont develop pancytopenia tends develop later type bone marrow transplant thing cures congenital amegakaryocytic thrombocytopenia frequent platelet transfusions required ensure platelet levels fall dangerous levels although always case known patients continue create small numbers platelets although hematopoietic stem cell transplantation shown cure congenital amegakaryocytic thrombocytopenia association early bone marrow aplasia worsens prognosis camt die complications bleeding die complications associated hematopoietic stem cell less cases congenital amegakaryocytic thrombocytopenia reported although incidence camt likely underestimated isolated camt may misdiagnosed neonatal alloimmune thrombocytopenia slight female preponderance edar edar hypohidrotic ectodermal dysplasia httpsenwikipediaorgwikicongenitalamegakaryocyticthrombocytopenia